Abstract
Schizophrenia is an incurable psychiatric disorder that has a prevalence of 0.5-1% of the world population. Currently, the diagnosis is strictly clinical, based on interviews conducted by psychiatrists, as there are no molecular biomarkers. Biomarkers for prediction of successful treatment are also non-existent, although indispensable due to lack of specificity of treatment for a signific…